Evan GI - Search Results

1

Validation of MdmX as a therapeutic target for reactivating p53 in tumors.

Garcia D, Warr MR, Martins CP, Brown Swigart L, Passegué E, Evan GI. Garcia D, et al. Among authors: evan gi. Genes Dev. 2011 Aug 15;25(16):1746-57. doi: 10.1101/gad.16722111. Genes Dev. 2011. PMID: 21852537 Free PMC article.

2

Temporal dissection of p53 function in vitro and in vivo.

Christophorou MA, Martin-Zanca D, Soucek L, Lawlor ER, Brown-Swigart L, Verschuren EW, Evan GI. Christophorou MA, et al. Among authors: evan gi. Nat Genet. 2005 Jul;37(7):718-26. doi: 10.1038/ng1572. Epub 2005 May 29. Nat Genet. 2005. PMID: 15924142 Free article.

3

Specific requirement for Bax, not Bak, in Myc-induced apoptosis and tumor suppression in vivo.

Dansen TB, Whitfield J, Rostker F, Brown-Swigart L, Evan GI. Dansen TB, et al. Among authors: evan gi. J Biol Chem. 2006 Apr 21;281(16):10890-5. doi: 10.1074/jbc.M513655200. Epub 2006 Feb 7. J Biol Chem. 2006. PMID: 16464852 Free article.

4

Reversible kinetic analysis of Myc targets in vivo provides novel insights into Myc-mediated tumorigenesis.

Lawlor ER, Soucek L, Brown-Swigart L, Shchors K, Bialucha CU, Evan GI. Lawlor ER, et al. Among authors: evan gi. Cancer Res. 2006 May 1;66(9):4591-601. doi: 10.1158/0008-5472.CAN-05-3826. Cancer Res. 2006. PMID: 16651409

5

Oncogene-dependent tumor suppression: using the dark side of the force for cancer therapy.

Evan GI, Christophorou M, Lawlor EA, Ringshausen I, Prescott J, Dansen T, Finch A, Martins C, Murphy D. Evan GI, et al. Cold Spring Harb Symp Quant Biol. 2005;70:263-73. doi: 10.1101/sqb.2005.70.054. Cold Spring Harb Symp Quant Biol. 2005. PMID: 16869762 Review.

6

The pathological response to DNA damage does not contribute to p53-mediated tumour suppression.

Christophorou MA, Ringshausen I, Finch AJ, Swigart LB, Evan GI. Christophorou MA, et al. Among authors: evan gi. Nature. 2006 Sep 14;443(7108):214-7. doi: 10.1038/nature05077. Epub 2006 Sep 6. Nature. 2006. PMID: 16957739

7

The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta.

Shchors K, Shchors E, Rostker F, Lawlor ER, Brown-Swigart L, Evan GI. Shchors K, et al. Among authors: evan gi. Genes Dev. 2006 Sep 15;20(18):2527-38. doi: 10.1101/gad.1455706. Genes Dev. 2006. PMID: 16980582 Free PMC article.

8

Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo.

Ringshausen I, O'Shea CC, Finch AJ, Swigart LB, Evan GI. Ringshausen I, et al. Among authors: evan gi. Cancer Cell. 2006 Dec;10(6):501-14. doi: 10.1016/j.ccr.2006.10.010. Cancer Cell. 2006. PMID: 17157790 Free article.

9

Modeling the therapeutic efficacy of p53 restoration in tumors.

Martins CP, Brown-Swigart L, Evan GI. Martins CP, et al. Among authors: evan gi. Cell. 2006 Dec 29;127(7):1323-34. doi: 10.1016/j.cell.2006.12.007. Epub 2006 Dec 21. Cell. 2006. PMID: 17182091 Free article.

10

Modelling Myc inhibition as a cancer therapy.

Soucek L, Whitfield J, Martins CP, Finch AJ, Murphy DJ, Sodir NM, Karnezis AN, Swigart LB, Nasi S, Evan GI. Soucek L, et al. Among authors: evan gi. Nature. 2008 Oct 2;455(7213):679-83. doi: 10.1038/nature07260. Epub 2008 Aug 17. Nature. 2008. PMID: 18716624 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters